Implementing Effective Clinical Protocols to Reduce Diagnostic and Treatment Delays in Patients with Fibrosing ILDs
Interprofessional Strategies for Mitigating Diagnostic and Treatment Delays in Patients With Fibrosing ILDs
Interactive Practice Guide
Fibrosing interstitial lung diseases (ILDs), encompassing a range of disorders such as idiopathic pulmonary fibrosis (IPF), progressive pulmonary fibrosis (PPF), and systemic autoimmune rheumatic disease-associated ILD (SARD-ILD), are rare diseases with symptoms that often overlap with other respiratory ailments, making it difficult to identify and diagnose. Real-world data have illuminated the detrimental impact of diagnostic delays on disease progression, underscoring the importance of prompt recognition and timely referral to specialized centers. Equally critical is the utilization of diagnostic tools, such as pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT) scans, to accurately identify and classify ILD subtypes, and monitor for SARD-ILD in at-risk patients. Prompt identification and classification allow for consensus on optimal management plans that consider both pulmonary and extrapulmonary disease aspects. Ultimately, the complexity of managing fibrosing ILDs necessitates a collaborative, multidisciplinary approach, demanding proficiency in the most up-to-date diagnostic techniques, therapeutic interventions, and supportive care.
Faculty: Shervin Assassi, MD, MS, Mark Yoder, MD
Release Date:
Expiration Date: August 15, 2026
Implementing Effective Clinical Protocols to Reduce Diagnostic and Treatment Delays in Patients With Fibrosing ILDs
Digital Quality ImprovementFaculty: Shervin Assassi, MD, MS, Mark Yoder, MD
Release Date:
Expiration Date: August 15, 2027
